Skip to main content

SPHERA FUNDS MANAGEMENT LTD.

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1496201 TEL AVIV, L3

Position in BBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,273,370
+$61,403 QoQ
Shares Held
245,346
+0.0% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
2.67%
of 13F equity value
Holder Rank
#94
of 469 holders
Holding Since
Dec 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Derivatives in BBIO

reported options exposure · as of Sep 30, 2025
CallValue
$6,752,200
CallShares
130,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $446,413,848 across 71 Biotechnology names. BBIO ranks #6 (4.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 BBIO
BridgeBio Pharma, Inc.
This page
245,346 $18,273,370

All Filings in BBIO

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,273,370 245,346
2026-03-31 $18,211,967 245,246
2025-12-31 $8,241,491 107,746
2025-09-30 $2,116,347 40,746
2025-09-30 $6,752,200 130,000
2025-06-30 $2,154,682 49,900
2025-06-30 $3,761,323 87,108
2025-03-31 $12,673,638 366,608
2024-12-31 $24,840,855 905,279
2024-09-30 $21,453,716 842,644
2024-06-30 $23,052,073 910,070
2024-06-30 $5,182,518 204,600
2024-03-31 $18,117,759 585,956
2024-03-31 $1,546,000 50,000
2023-12-31 $11,390,234 282,146
2023-09-30 $9,111,810 345,537
2023-06-30 $5,532,122 321,635
2023-06-30 $2,236,000 130,000
2023-03-31 $9,317,678 561,983
2023-03-31 $3,316,000 200,000
2021-03-31 $1,471,624 23,890
2020-12-31 $11,228,269 157,900